TY - JOUR
T1 - Modeling the lung
T2 - Design and development of tissue engineered macro- and micro-physiologic lung models for research use
AU - Nichols, Joan E.
AU - Niles, Jean A.
AU - Vega, Stephanie P.
AU - Argueta, Lissenya B.
AU - Eastaway, Adriene
AU - Cortiella, Joaquin
N1 - Publisher Copyright:
© 2014 by the Society for Experimental Biology and Medicine.
PY - 2014/9/1
Y1 - 2014/9/1
N2 - Respiratory tract specific cell populations, or tissue engineered in vitro grown human lung, have the potential to be used as research tools to mimic physiology, toxicology, pathology, as well as infectious diseases responses of cells or tissues. Studies related to respiratory tract pathogenesis or drug toxicity testing in the past made use of basic systems where single cell populations were exposed to test agents followed by evaluations of simple cellular responses. Although these simple single-cell-type systems provided good basic information related to cellular responses, much more can be learned from cells grown in fabricated microenvironments which mimic in vivo conditions in specialized microfabricated chambers or by human tissue engineered three-dimensional (3D) models which allow for more natural interactions between cells. Recent advances in microengineering technology, microfluidics, and tissue engineering have provided a new approach to the development of 2D and 3D cell culture models which enable production of more robust human in vitro respiratory tract models. Complex models containing multiple cell phenotypes also provide a more reasonable approximation of what occurs in vivo without the confounding elements in the dynamic in vivo environment. The goal of engineering good 3D human models is the formation of physiologically functional respiratory tissue surrogates which can be used as pathogenesis models or in the case of 2D screening systems for drug therapy evaluation as well as human toxicity testing. We hope that this manuscript will serve as a guide for development of future respiratory tract model systems as well as a review of conventional models.
AB - Respiratory tract specific cell populations, or tissue engineered in vitro grown human lung, have the potential to be used as research tools to mimic physiology, toxicology, pathology, as well as infectious diseases responses of cells or tissues. Studies related to respiratory tract pathogenesis or drug toxicity testing in the past made use of basic systems where single cell populations were exposed to test agents followed by evaluations of simple cellular responses. Although these simple single-cell-type systems provided good basic information related to cellular responses, much more can be learned from cells grown in fabricated microenvironments which mimic in vivo conditions in specialized microfabricated chambers or by human tissue engineered three-dimensional (3D) models which allow for more natural interactions between cells. Recent advances in microengineering technology, microfluidics, and tissue engineering have provided a new approach to the development of 2D and 3D cell culture models which enable production of more robust human in vitro respiratory tract models. Complex models containing multiple cell phenotypes also provide a more reasonable approximation of what occurs in vivo without the confounding elements in the dynamic in vivo environment. The goal of engineering good 3D human models is the formation of physiologically functional respiratory tissue surrogates which can be used as pathogenesis models or in the case of 2D screening systems for drug therapy evaluation as well as human toxicity testing. We hope that this manuscript will serve as a guide for development of future respiratory tract model systems as well as a review of conventional models.
KW - 3D lung models
KW - Engineered lung models
KW - engineered organ models
KW - micro-physiologic lung
KW - physiologic lung as a model
KW - upper respiratory tract models
UR - http://www.scopus.com/inward/record.url?scp=84907016366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907016366&partnerID=8YFLogxK
U2 - 10.1177/1535370214536679
DO - 10.1177/1535370214536679
M3 - Article
C2 - 24962174
AN - SCOPUS:84907016366
SN - 1535-3702
VL - 239
SP - 1135
EP - 1169
JO - Experimental Biology and Medicine
JF - Experimental Biology and Medicine
IS - 9
ER -